Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy

Annals of Surgical Oncology

Volumn 13, Issue 5, 2006, Pages 708-711

  Cox, Charles ^a   White, Laura ^a   Allred, Nathon ^a   Meyers, Michael ^a   Dickson, Daniel ^a   Dupont, Elisabeth ^a   Cantor, Alan ^a   Ly, Quan ^a   Dessureault, Sophie ^a   King, Jeff ^a   Nicosia, Santo ^a   Vrcel, Vesna ^a   Diaz, Nils ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Axillary staging; Breast cancer; Complete axillary lymph node dissection; Lymphatic mapping; Sentinel lymph nodes

Indexed keywords

DYE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; INSTITUTIONAL REVIEW; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PRACTICE GUIDELINE; SENTINEL LYMPH NODE BIOPSY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS;

EID: 33645848161     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/ASO.2006.05.017     Document Type: Article

References (12)

1. Canavese G, Gipponi M, Catturich A, et al. Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery. J Surg Oncol 2000; 74:61-8.
2. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999; 91:368-73.
3. Shivers S, Cox C, Leight G, et al. Final results of the Department of Defense multicenter breast lymphatic mapping trial. Ann Surg Oncol 2002; 9:248-55.
4. Hansen NM, Grube BJ, Giuliano AE. The time has come to change the algorithm for the surgical management of early breast cancer. Arch Surg 2002; 137:1131-5.
5. Cox C, Pendas S, Cox JM, et al. Guidelines for sentinel lymph node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg Oncol 1998; 227:645-53.
6. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349:546-53.
7. Huvos AG, Hutter RV, Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 1971; 173:44-6.
8. Jannink I, Fan M, Nagy S, et al. Serial sectioning of sentinel nodes in patients with breast cancer: a pilot study. Ann Surg Oncol 1998; 5:310-4.
9. Giuliano AE, Dale PS, Turner RR, et al. Improved staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 3:394-401.
10. Liberman L. Pathologic analysis of sentinel lymph nodes in breast carcinoma. Cancer 2000; 88:971-7.
11. Weiser MR, Montgomery L, Tan LK, et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg 2001; 8:145-9.
12. Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000; 89:574-81.